×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
0
Days
0
Hours
0
Minutes
0
Seconds


Monday, September 15th 2025
01pm to 01:45pm (GMT+2)

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
Add to calendar Notify me
 Browser notifications are enabled

Contexte :

 

Autour de deux cas cliniques, discussion du rôle de l’immunothérapie, chimiothérapie néoadjuvante et de la radio chimiothérapie et curiethérapie dans le cancer du col avancé avec les recommandations de Saint Paul Vence 2025.

 

Intervenants :

 

Dr Sarah Betrian Lagarde

Dr Abel Cordoba Largo

 

Programme :

 

Retour d’expérience de l’utilisation du pembrolizumab pour les cancers du col localement avancés dans la pratique quotidienneDr Sarah Betrian Lagarde & Dr Abel Cordoba Largo

 

Shooting date : 2025-09-15
Last update : 2025-06-19
Dr Sarah Betrian Lagarde
Toulouse , France
Oncology
Dr Abel Cordoba Largo
Lille, France
Radiotherapy

Suggestions

0
Days
0
Hours
0
Minutes
0
Seconds
Tuesday, July 1st 2025 from 01pm to 01:45pm (GMT+2)
Honolulu : Tuesday, July 1st 2025 from 01am to 01:45am (GMT+2)
San Francisco : Tuesday, July 1st 2025 from 04am to 04:45am (GMT+2)
New York : Tuesday, July 1st 2025 from 07am to 07:45am (GMT+2)
Buenos Aires : Tuesday, July 1st 2025 from 08am to 08:45am (GMT+2)
Reykjavik : Tuesday, July 1st 2025 from 11am to 11:45am (GMT+2)
London / Dublin : Tuesday, July 1st 2025 from 12pm to 12:45pm (GMT+2)
Paris / Berlin : Tuesday, July 1st 2025 from 01pm to 01:45pm (GMT+2)
Istanbul : Tuesday, July 1st 2025 from 02pm to 02:45pm (GMT+2)
Moscou / Dubaï : Tuesday, July 1st 2025 from 03pm to 03:45pm (GMT+2)
Bangkok : Tuesday, July 1st 2025 from 06pm to 06:45pm (GMT+2)
Shanghai : Tuesday, July 1st 2025 from 07pm to 07:45pm (GMT+2)
Tokyo : Tuesday, July 1st 2025 from 08pm to 08:45pm (GMT+2)
Sydney : Tuesday, July 1st 2025 from 10pm to 10:45pm (GMT+2)
Wellington : Wednesday, July 2nd 2025 from 12am to 12:45am (GMT+2)

Quels changements de pratique dans le cancer de l’ovaire en 1L après le congrès américain ?

Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

Last improvements in advanced ovarian cancer treatment

Trials that have or will impact practices in the management of patients with advanced ovarian cancer

Share
Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Tuesday, October 10th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Tuesday, October 10th 2023 from 09:30am to 11am (GMT+2)
New York : Tuesday, October 10th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Tuesday, October 10th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Tuesday, October 10th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Tuesday, October 10th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Tuesday, October 10th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Tuesday, October 10th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Tuesday, October 10th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Wednesday, October 11th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Wednesday, October 11th 2023 from 01:30am to 03am (GMT+2)
Sydney : Wednesday, October 11th 2023 from 03:30am to 05am (GMT+2)
Wellington : Wednesday, October 11th 2023 from 05:30am to 07am (GMT+2)

La prise en charge du cancer de l’ovaire chez la personne âgée : expériences croisées du CGFL ...

Cycle d'enseignement sur le cancer de l'ovaire - Deuxième session

Share
Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, January 31st 2024 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, January 31st 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, January 31st 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, January 31st 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, January 31st 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, January 31st 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, January 31st 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, February 1st 2024 from 04am to 05:30am (GMT+1)

KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...

Share
Scroll Up